VA Palo Alto Health Care System
Post Graduate Training
The Pharmacy Service is dedicated to the higher education and training of pharmacy professionals. We currently offer three residency programs with a total of nine available positions. Our programs include an American Society of Health-System Pharmacist (ASHP)-accredited Postgraduate Year One (PGY1) Pharmacy Practice Residency, a Postgraduate Year Two (PGY2) Psychiatric Pharmacy Residency and a PGY2 Administrative Pharmacy Residency.
This one-year postgraduate program provides training and experience in pharmacy practice and education. Patient care responsibilities are foremost; residents also receive instruction and experience in management, managed care, and research. A research project is required, and a focus on economics, epidemiology, outcomes analysis, or health-care policy is suggested but not mandatory.
The residency is a twelve-month postgraduate year two program that provides training and experience in Health System Pharmacy Administration. The program provides a basic foundation in all aspects of pharmacy administration and is flexible enough to adapt to the needs of the individual resident and consider the skill set that the resident brings to the program. It provides exposure to national, regional, and local activities that support safe and effective evidence-based medication use, performance improvement, strategic planning, regulatory compliance, human resource management, fiscal management, and effective use of automation/technology. A research project is required and a focus on economics, outcomes analysis, or health-care policy is suggested, but not mandatory.
Through a wide variety of clinical, research and managerial experiences, the resident will gain the knowledge and skills necessary to function as clinical pharmacy specialist in psychiatry and a leader in psychiatric pharmacy. Patient care responsibilities are foremost; residents will function as integral members of interdisciplinary teams caring for individuals with psychiatric and neurologic disorders and will assume responsibility for patient-centered medication therapy.